Cardiovascular protection from alcoholic drinks: Scientific basis of the French paradox;Protecção cardiovascular por bebidas alcoólicas: Bases científicas do paradoxo Francês

Revista Portuguesa de Cardiologia

Volumn 25, Issue 11, 2006, Pages 1043-1058

  Providência, Rui ^a  

^a CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

Author keywords

Cardioprotection; Ethanol; Ischemia reperfusion injury; Preconditioning; Resveratrol

Indexed keywords

ALCOHOL; ANTHOCYANIN; FLAVONOID; FUNGICIDE; QUERCETIN; RESVERATROL; TANNIN DERIVATIVE;

ALCOHOL CONSUMPTION; ALCOHOL METABOLISM; ALCOHOLIC BEVERAGE; ANTIOXIDANT ACTIVITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; HEART PROTECTION; HEMOSTASIS; HUMAN; ISCHEMIC PRECONDITIONING; LIPID METABOLISM; RED WINE; REVIEW; RISK REDUCTION; THROMBOCYTE AGGREGATION INHIBITION; VASODILATATION;

ALCOHOLIC BEVERAGES; CARDIOVASCULAR DISEASES; ETHANOL; FRANCE; HEART; HUMANS;

EID: 33846304183     PISSN: 08702551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (120)

1. World Health Report 2002: Reducing risks, promoting healthy life. Geneva, World Health Organization, 2002.
2. Monteiro P., Oliveira P.J., Gonçalves L., Providência L.A. Modulação Farmacológica da Função Mitocondrial no Contexto da Isquémia e Reperfusão. Rev Port Cardiol 2003;22 (3):407-429.
3. Stampfer M.J., Colditz G.A., Willett W.C., et al. A prospective study of moderate alcohol consumption and the risk of coronary disease and stroke in women. N Engl J Med 1988;319:267-273.
4. Klatsky A.L., Armstrong M.A., Friedman G.D. Relations of alcoholic beverage use to subsequent coronary artery disease hospitalization. Am J Cardiol 1986;58:710-714.
5. Handa K., Sasaki J., Saku K., et al. Alcohol consumption, serum lipids and severity of angiographically determined coronary artery disease. Am J Cardiol 1990;65:287-289.
6. Kiechl S., Willeit J., Egger G., et al. Alcohol consumption and carotid atherosclerosis: Evidence of dose-dependent atherogenic and antiatherogenic effects. Results from the Bruneck Study. Stroke 1994;25:1593-1598.
7. Woodward M., Tunstall-Pedoe H. Alcohol consumption, diet, coronary risk factors, and prevalent coronary heart disease in men and women in the Scottish Heart Health Study. J Epidemiol Community Health 1995;49:354-362.
8. Kiechl S., Willeit J., Rungger G., et al. Alcohol consumption and atherosclerosis: What is the relation? Prospective results from the Bruneck Study. Stroke 1998;29:900-907.
9. Thun M.J., Peto R, Lopez A.D., Monaco J.H., Henley S.J., Heath Jr C.W., Doll R. Alcohol consumption and mortality among middle-aged elderly US adults. N Engl J Med 1997;337:1705-1714.
10. Sesso H.D., Stampfer M.J., Rosner B., Hennekens C.H., Manson J.E., Gaziano J.M. Seven-year changes in alcohol consumption and subsequent risk of cardiovascular disease in men. Arch Intern Med 2000;160:2605-2612.
11. Yano K., Rhoads G.G., Kagan A. Coffee, alcohol and risk of coronary heart disease among Japanese men living in Hawaii. N Engl J Med 1977;297:405-409.
12. Scragg R., Stewart A., Jackson R., et al. Alcohol and exercise in myocardial infarction and sudden coronary death in men and women. American Journal of Epidemiology 1987;126:77-85.
13. Backwelder W.C., Yano K., Rhoads G.G., Kagan A., Gordon T. & Palesch Y. Alcohol and mortality: The Honolulu heart study. Am J Med 1980;68:164-169.
14. de Labry L.O., Glynn R.J., Levenson M.R., Hermos J.A., LoCastro J.S. & Vokonas P.S. Alcohol consumption and mortality in an American male population: recovering the U-shaped curve -findings from the normative aging study. Journal of Studies on Alcohol 1992;53:25-32.
15. Klatsky A.L., Armstrong M.A. & Friedman G.D. Risk of cardiovascular mortality in alcohol drinkers, ex-drinkers and nondrinkers. Am J Cardiol 1990;66:1237-1242.
16. Miller G.J., Beckles G.L.A., Maude G.H. & Carson D.C. Alcohol Consumption: Protection against Coronary Heart Disease and Risks to Health. Int J Epidemiol 1990;19:923-930.
17. Muntwyler J., Hennekens C.H., Buring J.E., Gaziano J.M. Mortality and light to moderate alcohol consumption after myocardial infarction. Lancet 1998;352:1882-1885.
18. de Logeril M., Salen P., Martin J.L., Boucher F., Paillard F., de Leiris J. Wine drinking and risks of cardiovascular complictaions after recent acute myocardial infarction. Circulation 2002;106:1465-1469.
19. Lucas DL, Brown RA, Wassef M, Giles TD. Alcohol and the cardiovascular system research challenges and opportunities. J Am Coll Cardiol 2005;45(12):1916-24.
20. Regan T.J. Alcoholic cardiomyopathy. Prog Cardiovasc Dis 1984:27:141-152.
21. Urbano-Marquez A., Estruch R., Navarro-Lopez F., et al. The effects of alcoholism on skeletal and cardiac muscle. N Engl J Med 1989;320:409415.
22. Klatsky A.L.: Blood pressure and alcohol intake, in Laragh JH, Brenner BM (eds). Hypertension: Pathophysiology, Diagnosis and Management. New York, NY, Raven, 1990, pgs 277-294.
23. Donahue R.P., Abbott R.D., Reed D.M., et al. Alcohol and hemorrhagic stroke. The Honolulu Heart Program. JAMA 1986;255:2311-2314.
24. Ettinger P.O., Wu C.F., De La Cruz C. Jr, et al. Arrhythmias and the "Holiday Heart": Alcohol-associated cardiac rhythm disorders. Am Heart J 1978;95:555-562.
25. Djousse L, Ellison RC, Beiser A, Scaramucci A, D'Agostino RB, Wolf PA. Alcohol consumption and risk of ischemic stroke: The Framingham Study. Stroke 2002 Apr;33(4):907-12.
26. Krenz M., Cohen M.V., Downey J., Protective and anti-protective effects of acute ethanol exposure in myocardial ischemia/reperfusion. Pathophysiology 2004;10:113-119.
27. Pagel P.S., Kersten J. R., Warltier D.C. Mechanisms of myocardial protection produced by chronic ethanol consumption. Pathophysiology 2004;10:121-129.
28. Gaziano J.M., Buring J.E., Breslow J.L., Goldhaber S.Z., Rosner B., VanDenburgh M., Willett W., Hennekens C.H. Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction. N Engl J Med 1993;329:1829-1834.
29. Pownall H.J. Alcohol: lipid metabolim and cardioprotection. Curr Atheroscler Rep 2002 Mar; 4(2)107-12.
30. Sato M., Maulik N., Das D.K. Cardioprotection with alcohol: role of both alcohol and polyphenolic antioxidants. Ann N Y Acad Sci 2002;957:122-135.
31. Zakhari S. Molecular mechanisms underlying alcohol-induced cardioprotection: contributions of hemostatic components. Introduction to the symposium. Alcohol Clin Exp Res 1999;23:1108-1110.
32. Booyse F.M., Aikens M.L. Grenett H.E. Endothelial cell fibrinolysis: transcriptional regulation of fibrinolytic protein gene expression (t-PA, u-PA, and PAI-1) by low alcohol. Alcohol Clin Exp Res 1999 Jun; 23 (6):1119-24.
33. Ridker P.M., Vaughan D.E., Stampfer M.J., Glynn R.J., Hennekens C.H. Association of moderate alcohol consumption and plasma concentrations of endogenous tissue-type plasminogen activator. J Am Med Assoc 1994;272:929-933.
34. Renaud S.C., Beswick A.D., Fehily A.M., Sharp D.S., Elwood P.C. Alcohol and platelet aggregation: the Caerphilly prospective heart disease study. Am J Clin Nutr 55 (1992) 1012-1017.
35. Demrow H.S., Slane P.R., Folts J.D. Administration of Wine and Grape Juice Inhibits In Vivo Platelet Activity and Thrombosis in Stenosed Canine Coronary Arteries. Circulation 1995;91:1182-1188.
36. Flesch M., Schwarz A., Bohm M. Effects of red and white wine on endothelium-dependent vasorelaxation of rat aorta and human coronary arteries. Am J Physiol 1998;275:H1183-H1190.
37. Su C.Y., Chong K.Y., Owen O.E., Dillman W.H., Chang C., Lai C.C. Constitutive and inducible hsp70s are involved in oxidative resistance evoked by heat shock or ethanol. J Mol Cell Cardiol 1998;30:587-598.
38. Lucas D.L., Brown R.A., Wassef M., Giles T.D. Alcohol and the Cardiovascular System - Research challenges and Opportunities. J Am Coll Cardiol 2005;45(12):1916-1924.
39. Rao M.N., Marmillot P., Gong M., Palmer D.A., Seff L.B., Strader D.B., Lakshman M.R. Light but not heavy alcohol drinking, stimulates paraoxonase by upregulating liver mRNA in rats and humans. Metabolism 2003;52(10):1287-1294.
40. La Du B.N. Human serum paraoxonase /arylesterase, in Kalow W(ed): Pharmacogenetics of Drug Metabolism. New York, NY, Pergamon, 1992, pgs 51-91.
41. Lakshman M.R., Chirtel S.J., Chambers L.L. Roles of omega 3 fatty acids and chronic ethanol in the regulation of plasma and liver lipids and plasma apoproteins A1 and E in rats. J Nutr 1998;118:1299-1303.
42. Lin R.C., Lumeng L., Phelps V.L. Serum high-density lipoprotein particles of alcohol-fed rats are deficient in apolipoprotein E. Hepatology 1989;9:307-313.
43. Rao M.N., Liu Q.H., Marmillot P, et al. High-density lipoproteins from human alcoholics exhibit impaired reverse cholesterol transport function. Metabolism 2000;49:1406-1410.
44. Huijberts M.S., Wolffenbuttel B.H., Boudier H.A., Crinjns F.R., Kruseman A.C., Poitevin P. & Levy B.I. Aminoguanidine treatment increases elasticity and decreases fluid filtration of large arteries from diabetic rats. J Clin Invest 1993;92:1407-1411.
45. Esposito C., Gerlach H., Brett J., Stern D. & Vlassara H. Endothelial receptor-mediated binding of glucose-modified albumin is associated with increased monolayer permeability and modulation of cell surface coagulant properties. J Exp Med 1989;170:1387-1407.
46. Bucala R., Makita Z., Vega G., Grundy S., Koschinsky T., Cerami A. & Vlassara H. Modification of Low Density Lipoprotein by Advanced Glycation End Products Contributes to the Dyslipidemia of Diabetes and Renal Insufficiency. Proc Natl Acad Sci USA 1994;91:9441-9445.
47. Bucala R., Mitchell R., Arnold K., Innerarity T., Vlassara H. & Cerami A. Identification of the Major Site of Apolipoprotein B Modification by Advanced Glycosylation End Products Blocking Uptake by the Low Density Lipoprotein Receptor. J Biol Chem 1995;270:10828-10832.
48. Al-Abed Y., Mitsuhashi T., Li H., Lawson J.A., FitzGerald G.A., Founds H., Donnelly T., Cerami A., Ulrich P., Bucala R. Inhibition of advanced glycation endproduct formation by acetaldehyde: Role in the cardioproteetive effect of ethanol. Proc Natl Acad Sci USA 1999 March;96:2385-2390.
49. Garlick P.B., Davies M.J., Hearse D.J. Slater T.F. Direct detection of free radicals in the reperfused rat heart using electron spin resonance spectroscopy. Circ Res 1987;61:757-760.
50. A.S., Bulkley G.B., Bulkely B.H., Flaherty J.T., Gott V.L., Gardner T.J. Oxygen free radical scavengers alone or together with other defense mechanisms, protect the arrested, globally ischemic heart upon reperfusion. Surg Forum 1983;34:313-316.
51. Black S.C., Lucchesi B.R. Heat shock proteins and the ischemic heart: an endogenous protective mechanism. Circulation 1993;87:1048-1051.
52. Marber M.S., Mestril R., Chi S-H, Sayen M.R., Yellon D.M., Dillmann W.H. Overexpression of the rat inducible 70-kD heat stress protein in a transgenic mouse increases the resistance of the heart to ischemic injury. J Clin Invest 1005;95:1446-1456.
53. Plumier J-CL, Ross B.M., Currie R.W., Angelidis C.E., Kaz-Laris G., Kollias G., Pagoulatos G.N. Transgenic mice expressing the human heat shock protein 70 have improved post-ischemic myocardial recovery. J Clin Invest 1993;95:1854-1860.
54. Hutter J.J., Mestril R., Tam Ekw, Siervers R.E., Dillmann W.H., Wolfe C.L. Overexpression of heat shock protein 72 in transgenic mice decreases infarct size in vivo. Circulation 1996;94:1408-1411.
55. Radford N.B., Fina M., Benjamin I.J., Moreadith R.W., Graves K.H., Zhao P., Gavva S., Weithoff A., Sherry A.D., Malloy C.R., Williams R.S. Cardioprotective effects of 70-kDa heat shock protein in transgenic mice. Proc Natl Acad Sci USA 1996;93:2339-2342.
56. Murry C.E., Jennings R.B., Reimer K.A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986;74:1124-1136.
57. Pagel P.S., Toller W.G., Gross E.R., Gare M., Kersten J.R., Warltier D.C. KATP channels mediate the beneficial effects of chronic ethanol ingestion. Am J Physiol 2000;279:H2574-H2579.
58. Chen C.-H., Gray M.O., Mochly-Rosen D. Cardioprotection from ischemia by a brief exposure to physiological levels of ethanol: role of epsilon protein kinase C. Proc Natl Acad Sci U.S.A. 1999;96(22):12784-9.
59. Liu G.S., Thornton J., Van Winkle D.M, Stanley A.W.H., Olsson R.A., Downey J.M. Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart. Circulation 1991;84:350-356.
60. Banerjee A., Locke-Winter C., Rogers K.B., Mitchell M.B., Brew E.C., Cairns C.B., Bensard D.D., Harken A.H. Preconditioning against myocardial dysfunction after ischemia and reperfusion by an α1-adrenergic mechanism. Circ Res 1993;73:656-670.
61. Schultz J.E.J., Rose E., Yao Z., Gross G.J. Evidence for involvement of opioid receptors in ischemic preconditioning in rat hearts. Am J Physiol 1995;268:H2157-H2161.
62. Wall T.M., Sheehy R., Hartman J.C. Role of bradykinin in myocardial preconditioning. J Pharmacol Exp Ther 1994;270:681-689.
63. Goto M., Liu Y., Yang X.-M., Ardell J.L., Cohen M.V., Downey J.M. Role of bradykinin in protection of ischemic preconditioning in rabbit hearts. Circ Res 1995;77:611-621.
64. Baines C.P., Goto M., Downey J.M. Oxygen radicals released during ischemic preconditioning contribute to cardioprotection in the rabbit myocardium. J Mol Cell Cardiol 1997;29:207-216.
65. Ytrehus K., Liu Y., Downey J.M. Preconditioning protects ischemic rabbit heart by protein kinase C activation. Am J Physiol 1994;266:H1145-H1152.
66. Mitchell M.B., Meng X., Ao L., Brown J.M., Harken A.H., Banerjee A. Preconditioning of isolated rat heart is mediated by protein kinase C. Circ Res 1995;76:73-81.
67. Maulik N., Watanabe M.,. Zu Y.-L, Huang C-K., Cordis G.A., Schley J.A., Das D.K. Ischemic preconditioning triggers the activation of MAP kinases and MAPKAP kinase 2 in rat hearts, FEBS Lett 1996;396:233-237.
68. Fryer R., Schultz J.E., Hsu A., Gross G., Tyrosine kinase is involved in the initiation of ischemic preconditioning in rats. FASEB J 12 (1998) A77.
69. Baines C.P., Wang L., Cohen M.V., Downey J.M. Protein tyrosine kinase is downstream of protein kinase C for ischemic preconditioning's anti-infarct effect in the rabbit heart. J Mol Cell Cardiol 1998;30:383-392.
70. Krenz M., Baines C.P., Heusch G., Downey J.M., Cohen M.V. Acute alcohol-induced protection against infarction in rabbit hearts: differences from and similarities to ischemic preconditioning. J Mol Cell Cardiol 2001;33:2015-2022.
71. Grover G.J., Garlid K.D. ATP-sensitive potassium channels: a review of their Cardioprotective pharmacology. J Mol Cell Cardiol 2000;32:677-695.
72. Kersten J.R., Schmeling T.J., Pagel P.S., Gross G.J., Warltier D.C. Isoflurane mimics ischemic preconditioning via activation of KATP channels: reduction of myocardial infarct size with an acute memory phase. Anesthesiology 87 (1997) 361-370.
73. Baxter G.F., Goma F.M., Yellon D.M. Characterisation of the infarct-limiting effect of delayed preconditioning: timecourse and dose-dependency studies in rabbit myocardium. Basic Res Cardiol 1997;92:159-167.
74. Miyamae M., Camacho S.A., Zhou H.-Z., Diamond I., Figueredo V.M. Alcohol consumption reduces ischemia-reperfusion injury by species-specific signaling in guinea pigs and rats. Am J Physiol 1998;275:H50-H56.
75. Kehl F., Krolikowski J.G., LaDisa Jr J.F., Kersten J.R., Warltier D.C., Pagel P.S. Adenosine type 1 (A1) receptors mediate protection against myocardial infarction produced by chronic, intermittent ingestion of ethanol in dogs. Int J Cardiol 2003;88:175-182.
76. Zhou H.-Z., Karliner J.S., Gray M.O. Moderate alcohol consumption induces sustained cardiac protection by activating PKC-ε and Akt. Am J Physiol 2002;283:H165-H174.
77. Krieg T., Landsberger M., Alexeyev M.F., Felix S.B., Cohen M. V., Downey J.M. Activation of Akt is essential for acetylcholine to trigger generation of oxygen free radicals. Cardiovasc Res 2003;58:196-202.
78. Bernardo N.L., D'Angelo M., Okubo S., Joy A., Kukreja R.C. Delayed ischemic preconditioning is mediated by opening of ATPsensitive potassium channels in the rabbit heart. Am J Physiol 1999;276:H1323-H1330.
79. Fujio Y., Nguyen T., Wencker D., Kitsis R.N., Walsh K. Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. Circulation 2000;101:660-667.
80. Matsui T., Tao J., Del Monte F., Lee K.H., Li L., Picard M., Force T.L., Franke T.F., Hajjar R.J., Rosenzweig A. Akt activation preserves cardiac function and prevents injury after transient cardiac ischemia in vivo. Circulation 2001;104:330-335.
81. Zhou H-Z., Karliner J.S., Gray M.O. Moderate alcohol consumption induces sustained cardiac protection by activating PKCε and Akt. Am J Physiol Heart Circ Physiol. 2002;283:H165-H174.
82. Simkhovich B.Z., Przyklenk K., Kloner R.A. Role of protein kinase C as a cellular mediator of ischemic preconditioning: a critical review. Cardiovasc Res 1998;40:9-22.
83. Hausenloy D. J., Yellon D.M. New directions for protecting the heart against ischaemia-reperfusion injury: targeting the reperfusion injury salvage kinase (RISK) pathway. Cardiovasc Res 2004;61:448-60.
84. Oliveira P.J., Rolo A.P., Seiça R., et al. Impact of diabetes on induction of the mitochondrial permeability transition. Rev Port Cardiol 2002; 21:759-66.
85. Ganote C., Armstrong S. Ischaemia and the myocyte cytoskeleton: review and speculation. Cardiovasc Res 1993;27:1387-1403.
86. Murry C.E., Richard V.J., Reimer K.A., Jennings R.B. Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic episode. Circ Res 1990;66:913-931.
87. Dos Santos P., Kowaltowski A.J., Laclau M.N., Seetharaman S., Paucek P., Boudina S., Thambo J.-B., Tariosse L., Garlid K.D. Mechanisms by which opening the mitochondrial ATP-sensitive K+ channel protects the ischemic heart. Am J Physiol 2002;283:H284-H295.
88. Wang S., Cone J., Liu Y. Dual roles of mitochondrial KATP channels in diazoxide-mediated protection in isolated rabbit hearts. Am J Physiol 2001;280:H246-H255.
89. Ohnuma Y., Miura T., Miki T., Tanno M., Kuno A., Tsuchida A., Shimamoto K. Opening of mitochondrial KATP channel occurs downstream of PKC-ε activation in the mechanism of preconditioning. Am J Physiol 2002;283:H440-H447.
90. Nichols C.G., Lederer W.J. The regulation of ATP-sensitive K+ channel activity in intact and permeabilized rat ventricular myocytes. J Physiol 1990;423:91-110.
91. Yao Z., Gross G.J. Effects of the KATP channel opener bimakalim on coronary blood flow, monophasic action potential duration, and infarct size in dogs. Circulation 1994;89:1769-1775.
92. Hamada K., Yamazaki J., Nagao T. Shortening of action potential duration is not prerequisite for cardiac protection by ischemic preconditioning or a KATP channel opener. J Mol Cell Cardiol 1998;30:1369-137.
93. Kersten J.R., Gross G.J., Pagel P.S., Warltier D.C. Activation of adenosine triphosphate-regulated potassium channels: mediation of cellular and organ protection. Anesthesiology 1998;88:495-513.
94. O'Rourke B. Myocardial KATP channels in preconditioning. Circ Res 2000;87:845-855.
95. Holmuhamedov E.L., Jovanovic S., Dzeja P.P., Jovanovic A., Terzic A. Mitochondrial ATP-sensitive K+ channels modulate cardiac mitochondrial function. Am J Physiol 1998;275:H1567-H1576.
96. Akao M., Ohler A., O'Rourke B., Marban E. Mitochondrial ATP-sensitive potassium channels inhibit apoptosis induced by oxidative stress in cardiac cells. Circ Res 2001;88:1267-1275.
97. Ozcan C., Bienengraeber M., Dzeja P.P., Terzic A. Potassium channel openers protect cardiac mitochondria by attenuating oxidant stress at reoxygenation. Am J Physiol 2002;282:H531-H539.
98. Gross G.J. The role of mitochondrial KATP channels in cardioprotection. Basic Res Cardiol 2000;95:280-284.
99. Sato T., Sasaki N., Seharaseyon J., O'Rourke B., Marbán E. Selective pharmacological agents implicate mitochondrial but not sarcolemmal KATP channels in ischemic cardioprotection. Circulation 2000;101:2418-2423.
100. Miyamae M., Diamond I., Weiner M.W., Camacho S.A., Figueredo V.M. Regular alcohol consumption mimics cardiac preconditioning by protecting against ischemia-reperfusion injury. Proc Natl Acad Sci USA 1997;94:3235-3239.
101. Zhu P., Zhou H.Z., Gray M.O. Chronic ethanol-induced myocardial protection requires activation of mitochondrial KATP channels. J Mol Cell Cardiol 2000;32:2091-2095.
102. Pagel P.S., Krolikowski J.G., Kehl F., Mraovic B., Kersten J.R., Warltier D.C. The role of mitochondrial and sarcolemmal KATP channels in canine ethanol-induced preconditioning in vivo. Anesth Analg 2002;94:841-848.
103. Krenz M., Baines C.P., Yang X.-M., Heusch G., Cohen M.V., Downey J.M. Acute ethanol exposure fails to elicit preconditioning-like protection in in situ rabbit hearts because of its continued presence during ischemia. J Am Coll Cardiol 2001;37:601-607.
104. Hale S.L., Kloner R.A. Ethanol does not exert myocardial preconditioning in an intact rabbit model of ischemia/reperfusion. Heart Dis 2001;3:293-296.
105. Inagaki K., Hahn H.S., Dorn G.W.II., Mochly-Rosen D. Additive protection of the ischemic heart ex vivo by combined treatment with deltaprotein kinase C inhibitor and epsilon-protein kinase C activator. Circulation 2003;108:869-75.
106. Inagaki K., Chen L., Ikeno F., Lee F.H., Imahashi K., Bouley D.M., et al. Inhibition of delta protein kinase C protects against reperfusion injury of the ischemic heart, in vivo. Circulation 2003;108:2304-7.
107. Inagaki K., Mochly-Rosen D. δPKC-mediated activation of εPKC in ethanol-induced cardiac protection from ischemia. J Mol Cell Cardiol 2005;39:203-211.
108. Sato M., Ray P.S., Maulik G., Nilanjana E., Richard M., Bertelli A.A.E., Bertelli A., Das D.K. Myocardial protection with red wine extract. J Cardiovasc Pharmacol 2000;35(2):263-268.
109. Wu J.M., Wang Z.R., Hsieh T.C., Bruder J.L., Zou J.G., Huang Y.Z. Mechanism of cardioprotection by resveratrol, a phenolic antioxidant present in red wine. Int J Mol Med 2001;8(1):3-17.
110. Rendig S.V., Symons J.D., Longhurst J.C., Amsterdam E.A. Effects of red wine, alcohol, and quercetin on coronary resistance and conductance arteries. J Cardiovasc Pharmacol 2001;38(2):219-27.
111. Pignatelli P., Pulcinelli F.M., Celestini A., Lenti L., Ghiselli A., Cazzaniga P.P., Violi F. The flavonoids quercetin and catechin synergistically inhibit platelet function by antagonizing the intracellular production of hydrogen peroxide. Am J Clin Nutr 2000;72(5):1150-1155.
112. Stein J.H., Keevil J.G., Wiebe D.A., Aeschlimann S., Folts J.D. Purple Grape Juice Improves Endothelial Function and Reduces the Susceptibility of LDL Cholesterol to Oxidation in Patients With Coronary Artery Disease. Circulation 1999;100:1050-1055.
113. Folts J.D. Potential health benefits from the flavonoids in grape products on vascular disease. In: Manthey J.A., ed. Flavonoids in Health and Disease. Washington, DC: Oxford University Press; 2001.
114. Grayston J.T. Background and current knowledge of Chlamydia pneumoniae and atheroschlerosis. J Infect Dis 2000;181(S3):S402-10.
115. Schriever C., Pendland S.L. Red wine, resveratrol, Chlamydia pneumoniae and the French connection. Atherosclerosis 2003;171:379-380.
116. Cui J., Tosaki A., Cordis C.A., Bertelli A.A.E., Bertelli A., Maulik N., Das D.K. Cardioprotective abilities of white wine. Ann NY Acad Sci 2002;957:308-316.
117. Chen C., Mochly-Rosen D. Opposing Effects of δ and εPKC. in Ethanol-induced Cardioprotection. J Mol Cell Cardiol 2001;33:581-585.
118. Mukamal K.J., Muller J.E., Maclure M., Sherwood J.B., Mittleman M.A. Lack of effect of recent alcohol consumption on the course of acute myocardial infarction. Am Heart J 1999;138:926-933.
119. Kloner R.A., Shook T., Przyklenk K., et al. Previous angina alters in-hospital outcome in TIMI-4: a clinical correlate to preconditioning? Circulation 1995;91:37-45.
120. Schultz J.E.J., Hsu A.K., Gross G.J. Morphine mimics the cardioprotective effect of ischemic preconditioning via a glibenclamide-sensitive mechanism in the rat heart. Circ Res 1996;78(6): 1100-4.